
Episode 118: Amar Sawhney, General Partner of Incept & CEO of Instylla and Rejoni | Brains, Sweat and Money: Self-Funding and Raising Capital for 25 Startups
Medtech Money
00:00
The Power of INSEP
The amount of money that is spent on the patent prosecution declined fractionally because now if three people shared access to the same patent for different fields, you only paid a third of the money required. This was very efficient for them. It was certainly very efficient for us at INSEP because we didn't pay anything and we owned this platform outright. And as these companies that licensed the products would create improvements, they would put the technology improvements back into INSEP and everybody else would benefit. So sort of created this ecosystem where everybody benefits from everybody else's improvements in their particular field of use. As long as they don't kind of go afoul of their field of use and they stay
Transcript
Play full episode